-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PFwjNl/SFZwjgurUmA6JJeRryeA0h/dsMExKZg9EBiN/g8pfF3M9ppSX3Ya4eQZK +F8LBJzhEwm3hFd9pSU5ZA== 0001072613-02-000294.txt : 20020414 0001072613-02-000294.hdr.sgml : 20020414 ACCESSION NUMBER: 0001072613-02-000294 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020212 GROUP MEMBERS: CANAAN EQUITY II ENTREPRENEURS LLC GROUP MEMBERS: CANAAN EQUITY II, L.P. GROUP MEMBERS: CANAAN EQUITY II, L.P. (QP) GROUP MEMBERS: CANAAN EQUITY PARTNERS II LLC GROUP MEMBERS: DEEPAK KAMRA GROUP MEMBERS: ERIC A. YOUNG GROUP MEMBERS: GREGORY KOPCHINSKY GROUP MEMBERS: GUY M. RUSSO GROUP MEMBERS: HARRY T. REIN GROUP MEMBERS: JAMES C. FURNIVALL GROUP MEMBERS: JOHN V. BALEN GROUP MEMBERS: STEPHEN L. GREEN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ESPERION THERAPEUTICS INC/MI CENTRAL INDEX KEY: 0001066745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383419139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60849 FILM NUMBER: 02536823 BUSINESS ADDRESS: STREET 1: 3621 S STATE STREET 695KMS PLACE STREET 2: 734-332-0506 CITY: ANN ARBOR STATE: MI ZIP: 48108 MAIL ADDRESS: STREET 1: 3621 STATE STREET STREET 2: 695 KMS PLACE CITY: ANN ARBOR STATE: MI ZIP: 48108 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CANAAN EQUITY II LP CENTRAL INDEX KEY: 0001097958 IRS NUMBER: 061559823 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 105 ROWAYTON AVENUE CITY: ROWAYTON STATE: CT ZIP: 06853 BUSINESS PHONE: 2038550400 SC 13G/A 1 sch13g_11030a.txt SCHEDULE 13G/A - ESPERION THERAPEUTICS, INC. ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Esperion Therapeutics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 29664R106 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2001 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ =================== ================== CUSIP NO. 29664R106 13G PAGE 2 OF 9 PAGES =================== ================== Item 1(a). Name of Issuer -------------- Esperion Therapeutics, Inc. Item 1(b). Address of Issuer's Principal Executive Offices ----------------------------------------------- 3261 S. State Street, 695 KMS Place Ann Arbor, MI 48108 Item 2(a). Name of Person Filing --------------------- This statement is filed by Canaan Equity II L.P. ("CE II"), a Delaware limited partnership, Canaan Equity II L.P. (QP) ("CE II QP"), a Delaware limited partnership, Canaan Equity II Entrepreneurs LLC ("Entrepreneurs"), a Delaware limited liability company, Canaan Equity Partners II LLC ("CEP II"), a Delaware limited liability company and the General Partner of CE II and CE II QP and the Manager of Entrepreneurs, and Harry T. Rein, John V. Balen, James C. Furnivall, Stephen L. Green, Deepak Kamra, Gregory Kopchinsky, Guy M. Russo and Eric A. Young. CE II, CE II QP, Entrepreneurs, CEP II, and Messrs. Rein, Balen, Furnivall, Green, Kamra, Kopchinsky, Russo and Young (who serve as Managers of CEP II) are collectively referred to as the "Reporting Persons". Item 2(b). Address of Principal Business Office or, if None, Residence ----------------------------------------------------------- Except in the case of John V. Balen, Deepak Kamra and Eric A. Young, the principal business address of the Reporting Persons is 105 Rowayton Avenue, Rowayton, CT 06853. The principal business address of John V. Balen, Deepak Kamra and Eric A. Young is 2884 Sand Hill Road, Suite 115, Menlo Park, CA 94025. Item 4. Ownership --------- Not Applicable. Item 5. Ownership of Five Percent or Less of a Class -------------------------------------------- Each Reporting Person ceased to own beneficially more than 5% of the outstanding Common Stock of Esperion Therapeutics, Inc. as of December 31, 2001. ALL OTHER ITEMS REPORTED ON THE SCHEDULE 13G DATED AS OF FEBRUARY 14, 2001 AND FILED ON BEHALF OF THE REPORTING PERSONS WITH RESPECT TO THE COMMON STOCK OF ESPERION THERAPEUTICS, INC. REMAIN UNCHANGED. DATE: February 12, 2002 =================== ================== CUSIP NO. 29664R106 13G PAGE 3 OF 9 PAGES =================== ================== SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Canaan Equity II L.P. By: Canaan Equity Partners II LLC Its General Partner By: * ------------------------ Manager Canaan Equity II L.P. (QP) By: Canaan Equity Partners II LLC Its General Partner By: * ------------------------ Manager Canaan Equity II Entrepreneurs LLC By: Canaan Equity Partners II LLC Its Manager By: * ------------------------ Manager Canaan Equity Partners II LLC By: * ------------------------ Manager * - --------------------------------- Harry T. Rein =================== ================== CUSIP NO. 29664R106 13G PAGE 4 OF 9 PAGES =================== ================== * - --------------------------------- John V. Balen * - --------------------------------- James C. Furnivall * - --------------------------------- Stephen L. Green * - --------------------------------- Deepak Kamra * - --------------------------------- Gregory Kopchinsky * - --------------------------------- Guy M. Russo * - --------------------------------- Eric A. Young *By: /s/ Guy M. Russo ---------------------- Guy M. Russo Attorney-in-Fact - -------------------------------------------------------------------------------- This Schedule 13G was executed by Guy M. Russo pursuant to Powers of Attorney a copy of which is filed herewith as Exhibit 2. =================== ================== CUSIP NO. 29664R106 13G PAGE 5 OF 9 PAGES =================== ================== EXHIBIT 1 --------- JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13G need be filed by each of the undersigned with respect to the ownership by each of the undersigned of shares of stock of Esperion Therapeutics, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. Canaan Equity II L.P. By: Canaan Equity Partners II LLC Its General Partner By: * ------------------------ Manager Canaan Equity II L.P. (QP) By: Canaan Equity Partners II LLC Its General Partner By: * ------------------------ Manager Canaan Equity II Entrepreneurs LLC By: Canaan Equity Partners II LLC Its Manager By: * ------------------------ Manager Canaan Equity Partners II LLC By: * ------------------------ Manager * - --------------------------------- Harry T. Rein =================== ================== CUSIP NO. 29664R106 13G PAGE 6 OF 9 PAGES =================== ================== * - --------------------------------- John V. Balen * - --------------------------------- James C. Furnivall * - --------------------------------- Stephen L. Green * - --------------------------------- Deepak Kamra * - --------------------------------- Gregory Kopchinsky * - --------------------------------- Guy M. Russo * - --------------------------------- Eric A. Young *By: /s/ Guy M. Russo ---------------------- Guy M. Russo Attorney-in-Fact - -------------------------------------------------------------------------------- This Schedule 13G was executed by Guy M. Russo pursuant to Powers of Attorney a copy of which is filed herewith as Exhibit 2. =================== ================== CUSIP NO. 29664R106 13G PAGE 7 OF 9 PAGES =================== ================== EXHIBIT 2 --------- POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Guy M. Russo his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities (until revoked in writing) to sign any and all instruments, certificates and documents required to be executed on behalf of himself as an individual or in his capacity as a general partner or authorized signatory, as the case may be, on behalf of any of Canaan Equity II L.P., Canaan Equity II L.P. (QP), Canaan Equity II Entrepreneurs LLC and Canaan Equity Partners II LLC pursuant to the Securities Act of 1933, as amended, (the "Securities Act"), or the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Securities Act, the Exchange Act or by the By-laws of the National Association of Securities Dealers, Inc., granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he might or could do in person thereby, and ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof, or may have done in connection with the matters described above. [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] =================== ================== CUSIP NO. 29664R106 13G PAGE 8 OF 9 PAGES =================== ================== IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 14th day of February, 2001. CANAAN EQUITY II L.P. By: Canaan Equity Partners II LLC Its General Partner By: /s/ Harry T. Rein --------------------------- Member/Manager CANAAN EQUITY II L.P. (QP) By: Canaan Equity Partners II LLC Its General Partner By: /s/ Harry T. Rein --------------------------- Member/Manager CANAAN EQUITY II ENTREPRENEURS LLC By: Canaan Equity Partners II LLC Its General Partner By: /s/ Harry T. Rein --------------------------- Member/Manager CANAAN EQUITY PARTNERS II LLC By: /s/ Harry T. Rein --------------------------- Member/Manager /s/ Harry T. Rein - --------------------------------- Harry T. Rein /s/ John V. Balen - --------------------------------- John V. Balen /s/ James C. Furnivall - --------------------------------- James C. Furnivall =================== ================== CUSIP NO. 29664R106 13G PAGE 9 OF 9 PAGES =================== ================== /s/ Stephen L. Green - --------------------------------- Stephen L. Green /s/ Deepak Kamra - --------------------------------- Deepak Kamra /s/ Guy M. Russo - --------------------------------- Guy M. Russo /s/ Gregory Kopchinsky - --------------------------------- Gregory Kopchinsky /s/ Eric A. Young - --------------------------------- Eric A. Young -----END PRIVACY-ENHANCED MESSAGE-----